Muscle preservation during GLP-1 or medical weight-loss treatment depends heavily on protein intake, resistance training, adequate nutrition, dose management, sleep, hormones, and medical monitoring
Zhang K, et al
Compounded products do not have the same safety, quality, and effectiveness assurances as FDA-approved drugs, and adulterated and misbranded injectable compounded drugs may expose patients to significant health risks, Jason Brett, executive director of medical affairs at Novo, said in a press release
second-generation long-acting analogues such as cagrilintide under late-stage clinical development, often combined with GLP-1 therapy for enhanced weight loss), (b) small molecules or peptides designed to inhibit amylin misfolding and aggregation to protect -cells, and (c) immunotherapeutic or vaccine approaches targeting pathological IAPP species
It has been proposed that GLP-1 could promote c-Fos transcription in osteoblasts in combination with ATP, facilitating the participation of GLP-1 in bone turnover ( Suppression of Bone Resorption and Possible Mechanisms GLP-1 Inhibits Bone Resorption Glucagon-like peptide-1 has an impact on the number and functioning of osteoclasts
